Sensus Healthcare, Inc. (SRTS) Trades at $5.37 After Triangle; Repsol, S.A. (REPYY) Covered By 1 Bulls

Sensus Healthcare, Inc. (SRTS) formed triangle with $5.05 target or 6.00% below today’s $5.37 share price. Sensus Healthcare, Inc. (SRTS) has $72.41M valuation. The stock decreased 3.02% or $0.167 during the last trading session, reaching $5.368. About 3,667 shares traded. Sensus Healthcare, Inc. (NASDAQ:SRTS) has 0.00% since January 31, 2017 and is . It has underperformed by 16.70% the S&P500.

Among 7 analysts covering Repsol SA (OTCMKTS:REPYY), 1 have Buy rating, 1 Sell and 5 Hold. Therefore 14% are positive. Repsol SA had 10 analyst reports since August 21, 2015 according to SRatingsIntel. The firm has “Equal Weight” rating by Barclays Capital given on Friday, August 21. The rating was downgraded by Goldman Sachs on Tuesday, February 21 to “Neutral”. The stock of Repsol, S.A. (OTCMKTS:REPYY) earned “Hold” rating by Macquarie Research on Wednesday, June 21. The rating was reinitiated by Goldman Sachs on Friday, September 11 with “Sell”. The rating was upgraded by Goldman Sachs on Wednesday, November 4 to “Neutral”. The company was maintained on Friday, October 16 by RBC Capital Markets. Bernstein downgraded Repsol, S.A. (OTCMKTS:REPYY) on Thursday, September 8 to “Underperform” rating. Jefferies upgraded the shares of REPYY in report on Friday, September 11 to “Hold” rating. The rating was downgraded by Barclays Capital on Monday, August 21 to “Hold”. On Tuesday, September 5 the stock rating was upgraded by Morgan Stanley to “Buy”. See Repsol, S.A. (OTCMKTS:REPYY) latest ratings:

05/09/2017 Broker: Morgan Stanley Rating: Buy Upgrade
21/08/2017 Broker: Barclays Capital Rating: Hold New Target: $19.0 Downgrade

The stock decreased 1.67% or $0.32 during the last trading session, reaching $18.79. About shares traded. Repsol, S.A. (OTCMKTS:REPYY) has 0.00% since January 31, 2017 and is . It has underperformed by 16.70% the S&P500.

Repsol, S.A., an integrated energy company, engages in upstream and downstream activities worldwide. The company has market cap of $27.31 billion. It explores for, develops, and produces natural gas and crude oil; transports oil products, liquefied petroleum gas , and natural gas; refines and produces a range of oil products; and retails oil products, oil derivatives, petrochemicals, LPG, natural gas, and liquefied natural gas (LNG). It has a 10.57 P/E ratio. The firm offers asphalts; AutoGas, an alternative to traditional fuels; petrol, gas oils, fuel oils, and petcoke; aviation fuels; butane and propane gases; lubricants; and ethylene vinyl acetate copolymers, polyols, polypropylene, propylene oxide/styrene, polyethylene, glycols, petrochemicals, rubber, intermediate distillates, and hydrocarbons.

Analysts await Sensus Healthcare, Inc. (NASDAQ:SRTS) to report earnings on February, 1. After $-0.07 actual EPS reported by Sensus Healthcare, Inc. for the previous quarter, Wall Street now forecasts 14.29% negative EPS growth.